| 股號 / 名稱 | 總負債 | 淨值 |
| NVO 諾和諾德 | 1,732,237,683,159.08 | 963,539,366,510.35 |
| BSX Boston Scientific Corp | 613,663,182,561.6 | 764,963,986,780.62 |
| SYK 史賽克 | 802,560,326,823.36 | 707,732,950,258.8 |
| PHG Koninklijke Philips NV | 592,734,103,125.21 | 406,304,285,127.36 |
| ZBH Zimmer Biomet Holdings Inc | 327,852,080,646.43 | 401,084,447,787.61 |
| BIO Bio Rad Laboratories Inc | 98,580,697,161.61 | 235,288,060,573.1 |
| RMD 瑞思邁 | 68,894,772,272.22 | 199,531,415,829.57 |
| NVST Envista Holdings Corp | 81,212,513,877.38 | 98,056,684,361.68 |
| ICUI ICU Medical Inc | 62,365,288,681.85 | 67,150,977,628.81 |
| NEOG Neogen Corp | 39,631,309,027.51 | 66,432,448,752.2 |
| QDEL QuidelOrtho Corp | 121,495,208,695.63 | 60,624,492,906.87 |
| EYE National Vision Holdings Inc | 34,714,616,880.56 | 27,108,539,522.62 |
| INMD Inmode Ltd | 2,627,355,984.97 | 21,566,535,956.78 |
| TGTX TG Therapeutics Inc | 13,188,897,101.51 | 19,168,072,550.86 |
| ATRC AtriCure Inc | 5,017,106,888.91 | 15,041,913,689.96 |
| WRBY Warby Parker Inc | 10,647,435,021.88 | 11,667,965,733.25 |
| BLFS BioLife Solutions Inc | 1,210,343,299.68 | 11,166,491,797.13 |
| PAHC Phibro Animal Health Corp | 33,877,490,649.16 | 10,491,651,698.53 |
| QTRX Quanterix Corp | 4,091,277,285.96 | 9,928,906,145.26 |
| MRVI Maravai LifeSciences Holdings Inc | 19,058,534,935.45 | 7,747,908,051.31 |
| ORMP Oramed Pharmaceuticals Inc | 543,300,259.01 | 6,417,010,240.61 |
| VALN Valneva SE | 11,030,652,279.72 | 5,574,637,493.94 |
| VMD Viemed Healthcare Inc | 2,170,296,868.7 | 4,217,608,564.59 |
| UTMD Utah Medical Products Inc | 117,524,075.55 | 3,732,865,157.63 |
| CAPR Capricor Therapeutics Inc | 1,343,838,717.16 | 2,647,440,827.38 |
| MGNX MacroGenics Inc | 6,432,162,417.96 | 2,115,022,988.42 |
| CERS Cerus Corp | 4,852,547,929.51 | 1,940,204,742.27 |
| INFU InfuSystem Holdings Inc | 1,370,325,038.84 | 1,751,055,061.72 |
| ZVIA Zevia PBC | 276,495,669.55 | 1,617,810,602.18 |
| VERU Veru Inc | 329,654,242.74 | 1,171,895,912.34 |
| RMTI Rockwell Medical Inc | 646,050,961.64 | 1,168,611,677.9 |
| ICCC ImmuCell Corp | 502,840,157.44 | 940,724,193.28 |
| XGN Exagen Inc | 1,410,573,009.92 | 572,562,901.51 |
| MYO Myomo Inc | 614,037,251.94 | 461,686,212.43 |
| SNES Senestech Inc | 103,413,610.39 | 358,222,726.12 |
| UG United-Guardian Inc | 50,441,282.72 | 334,056,265.93 |
| PHGE Biomx Inc | 495,034,260.75 | 331,011,940.96 |
| NEPH Nephros Inc | 102,308,764.13 | 315,859,763.62 |
| CLRB Cellectar Biosciences Inc | 165,672,013.09 | 296,077,649.08 |
| CTSO Cytosorbents Corp | 1,159,457,237.42 | 284,734,665.98 |
| APYX Apyx Medical Inc | 1,626,239,000.82 | 184,604,027.35 |
| IMCC IM Cannabis Corp | 915,797,025.92 | 89,903,233.02 |
| GCTK GlucoTrack Inc | 174,849,813.18 | 86,840,916.42 |
| EOLS Evolus Inc | 7,820,954,172.94 | -907,867,959.39 |
| OMER Omeros Corp | 12,822,025,007.49 | -6,959,836,994.07 |
| BRBR Bellring Brands Inc | 49,591,813,775.94 | -16,121,285,356.7 |
載入數據中...
最新要聞
和醫療產品相關的產業概念股
醫療產品概念股相關指標排名
醫療產品每月營收
醫療產品每股盈餘
醫療產品每股淨值
醫療產品損益表
醫療產品總資產
醫療產品負債和股東權益
醫療產品現金流量表
醫療產品利潤比率
醫療產品營業費用率拆解
醫療產品杜邦分析
醫療產品ROE / ROA
醫療產品經營週轉能力
醫療產品營運週轉天數
醫療產品現金股利發放率
醫療產品財務結構比率
醫療產品流速動比率
醫療產品利息保障倍數
醫療產品現金流量分析
醫療產品營業現金流對淨利比
醫療產品盈餘再投資比率
醫療產品月營收成長率
醫療產品營收成長率
醫療產品毛利成長率
醫療產品營業利益成長率
醫療產品稅後淨利成長率
醫療產品每股盈餘成長率
醫療產品本益比評價
醫療產品股價淨值比評價
醫療產品現金股利殖利率
醫療產品平均現金股息殖利率
醫療產品董監持股比例
醫療產品董監持股質押比例